StockData
CVS HEALTH Corp logo

CVS HEALTH Corp

CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/3016% above fair value
$88.51−1.74 (-1.93%)

Close on Nov 2, 2026Market cap $113.20BP/E 23.5Yield 3.01%

Cvs Health Available-for-Sale (AFS) Debt Securities by Quarter

Available-for-Sale (AFS) Debt Securities — Fair Value ($M)

QuarterlyAnnual

Cvs Health Available-for-Sale (AFS) Debt Securities: $29,349M in Q2 2026, up 10.5% from a year earlier. That is the highest of the 30 quarters on record here.

Latest, Q2 2026
29,349
Period ended Jun 30, 2026
Change on a year earlier
+10.5%
26,554 in Q2 2025
History
30 quarters
Since Q4 2018
Sources
2
Documents cited below

Where the Q2 2026 figure comes from

Source: CVS SEC 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtSecurities) ↗

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedAvailable-for-Sale (AFS) Debt Securities — Fair Value ($M)Year on yearSource
Q2 2026Jun 30, 202629,349+10.5%CVS SEC 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtSecurities) ↗
Q1 2026Mar 31, 202628,391+9.0%CVS SEC 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtSecurities) ↗
Q4 2025Dec 31, 202528,718+10.3%CVS SEC 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtSecurities) ↗
Q3 2025Sep 30, 202527,835+5.1%CVS SEC 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtSecurities) ↗
Q2 2025Jun 30, 202526,554+11.4%CVS SEC 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtSecurities) ↗
Q1 2025Mar 31, 202526,044+15.1%CVS SEC 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtSecurities) ↗
Q4 2024Dec 31, 202426,033+19.9%CVS SEC 10-K (XBRL us-gaap:AvailableForSaleSecuritiesDebtSecurities) ↗
Q3 2024Sep 30, 202426,490+29.8%CVS SEC 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtSecurities) ↗
Q2 2024Jun 30, 202423,831+14.0%CVS SEC 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtSecurities) ↗
Q1 2024Mar 31, 202422,626+8.7%CVS SEC 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtSecurities) ↗
Q4 2023Dec 31, 202321,713+7.1%CVS SEC 10-K (XBRL us-gaap:AvailableForSaleSecuritiesDebtSecurities) ↗
Q3 2023Sep 30, 202320,401+1.8%CVS SEC 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtSecurities) ↗
Q2 2023Jun 30, 202320,903+0.7%CVS SEC 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtSecurities) ↗
Q1 2023Mar 31, 202320,822-7.4%CVS SEC 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtSecurities) ↗
Q4 2022Dec 31, 202220,280-12.7%CVS SEC 10-K (XBRL us-gaap:AvailableForSaleSecuritiesDebtSecurities) ↗
Q3 2022Sep 30, 202220,040-11.2%CVS SEC 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtSecurities) ↗

Breakdown

What makes up available-for-Sale (AFS) Debt Securities

Cite this data

StockData. (2026). Cvs Health Available-for-Sale (AFS) Debt Securities ($M), quarterly Q4 2018–Q2 2026 [Data set]. Compiled from Cvs Health SEC filings and investor materials. https://stockdatahq.com/stocks/cvs/kpis/inv-afs-debt-fv

See every metric in the Cvs Health KPI table. Data updated Oct 28, 2026.